Gene · 55894
Papers2,388
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,388
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptome-Derived Ligand-Receptor Interactome of Major PitNET Subgroups. | J Neurol Surg B Skull Base | 2024 | 38966297 | PubTator, text mining | PubMed |
| Insights into Intrinsic Atopic Dermatitis: immunogenicity, Dysbiosis, and Imaging (Reflectance Confocal Microscopy, Optical Coherence Tomography). | Clin Cosmet Investig Dermatol | 2024 | 38881699 | PubTator, text mining | PubMed |
| Endotypes of Chronic Rhinosinusitis with Primary and Recurring Nasal Polyps in the Latvian Population. | Int J Mol Sci | 2024 | 38791197 | PubTator, text mining | PubMed |
| Antifungal activity of human antimicrobial peptides targeting apoptosis in Candida auris. | J Med Microbiol | 2024 | 38743468 | PubTator, text mining | PubMed |
| The Relationship between Tumor Budding and Tumor Deposits in Patients with Stage III Colorectal Carcinoma. | J Clin Med | 2024 | 38731112 | PubTator, text mining | PubMed |
| TLR4/7-mediated host-defense responses of gingival epithelial cells. | J Cell Biochem | 2024 | 38726711 | PubTator, text mining | PubMed |
| Change in Tissue Microbiome and Related Human Beta Defensin Levels Induced by Antibiotic Use in Bladder Carcinoma. | Int J Mol Sci | 2024 | 38674148 | PubTator, text mining | PubMed |
| A computational approach to design a multiepitope vaccine against H5N1 virus. | Virol J | 2024 | 38509569 | PubTator, text mining | PubMed |
| Beta-defensin index: A functional biomarker for oral cancer detection. | Cell Rep Med | 2024 | 38442713 | PubTator, text mining | PubMed |
| In vitro activity of human defensins HNP-1 and hBD-3 against multidrug-resistant ESKAPE Gram-negatives of clinical origin and selected peptidoglycan recycling-defective mutants. | Microbiol Spectr | 2024 | 38441982 | PubTator, text mining | PubMed |
| The prognostic value of tumor budding in a thoroughly characterized stage II colon cancer population in the context of a national screening program. | Hum Pathol | 2024 | 38428823 | PubTator, text mining | PubMed |
| Human beta defensin 3 knockdown inhibits the proliferation and migration of airway smooth muscle cells through regulating the PI3K/AKT signaling pathway. | Mol Immunol | 2024 | 38422885 | PubTator, text mining | PubMed |
| Mechanism of action of adapalene for treating EGFR-TKI-induced skin disorder. | Thorac Cancer | 2024 | 38379420 | PubTator, text mining | PubMed |
| A genome-wide CRISPR screen identified host genes essential for intracellular Brucella survival. | Microbiol Spectr | 2024 | 38376367 | PubTator, text mining | PubMed |
| Human β-Defensin 3 Inhibition of P. gingivalis LPS-Induced IL-1β Production by BV-2 Microglia through Suppression of Cathepsins B and L. | Cells | 2024 | 38334675 | PubTator, text mining | PubMed |
| Antimicrobial peptides and other potential biomarkers of critical illness in SARS-CoV-2 patients with acute kidney injury. AMPAKI-CoV study. | Physiol Rep | 2024 | 38328863 | PubTator, text mining | PubMed |
| Dynamic changes of Th1/Th2/Th17 cytokines and hBD-2/3 in erosive oral lichen planus patients saliva before and after prednisone acetate treatment. | Heliyon | 2024 | 38283247 | PubTator, text mining | PubMed |
| Establish a novel tumor budding-related signature to predict prognosis and guide clinical therapy in colorectal cancer. | Sci Rep | 2024 | 38273073 | PubTator, text mining | PubMed |
| Salivary Th17 cytokine, human β-defensin 1-3, and salivary scavenger and agglutinin levels in Crohn's disease. | Clin Oral Investig | 2024 | 38246944 | PubTator, text mining | PubMed |
Combination antimicrobial therapy: in vitro synergistic effect of anti-staphylococcal drug oxacillin with antimicrobial peptide nisin against Staphylococcus epidermidis clinical isolates and Staphylococcus aureus biofilms. | Ann Clin Microbiol Antimicrob | 2024 | 38245727 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55894/papers?page=5